Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice

T. Onzuka, Y. Tomita, S. Okano, I. Shimizu, H. Yamada, Y. Yoshikai, R. Tominaga

Research output: Contribution to journalArticle

Abstract

We reported that invariant NKT-cell knockout (iNKT KO) mice are resistant to the induction of intrathymic chimerism and clonal deletion in the cyclophosphamide (CP)-induced tolerance system (CPS). However, another report shows that clonal deletion with chimerism may be intact in iNKT KO recipients in a bone marrow transplantation model. We also reported that pretreatment with anti-Thy1.2 mAb, which reduces the number of T cells and iNKT cells, promotes allograft tolerance across H-2 barriers in the CPS. In this study, we evaluated the efficacy of T-cell depletion in the CPS, and the relationship between the role played by iNKT cells in central tolerance and mixed chimerism. BALB/c (H-2d) wild-type, or iNKT KO (Jα18-/-) mice were pretreated with 20-100 μg of anti-Thy1.2 mAb and given 108 donor DBA/2 (H-2d) spleen cells on Day 0, and 200 mg/kg CP on Day 2. Pretreatment with T-cell depletion resulted in higher levels of mixed chimerism, increased intrathymic clonal deletion of donor-reactive cells, and the induction of skin graft tolerance in iNKT KO recipients in CPS. This suggests that the high levels of mixed chimerism overcame the resistance to CP-induced tolerance in iNKT KO mice. Consistently, the enhancement of mixed chimerism by injection of tolerant donor spleen cells (SC) rendered iNKT KO recipients susceptible to CP-induced tolerance. These results suggest that iNKT-cell-mediated immunoregulation of central tolerance is evident at low levels of peripheral mixed chimerism in the CPS.

Original languageEnglish
Pages (from-to)106-117
Number of pages12
JournalScandinavian Journal of Immunology
Volume72
Issue number2
DOIs
Publication statusPublished - Aug 1 2010

Fingerprint

Chimerism
Natural Killer T-Cells
Cyclophosphamide
T-Lymphocytes
Antibodies
Clonal Deletion
Central Tolerance
Knockout Mice
Transplantation Tolerance
Spleen
Bone Marrow Transplantation
Skin
Injections

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice. / Onzuka, T.; Tomita, Y.; Okano, S.; Shimizu, I.; Yamada, H.; Yoshikai, Y.; Tominaga, R.

In: Scandinavian Journal of Immunology, Vol. 72, No. 2, 01.08.2010, p. 106-117.

Research output: Contribution to journalArticle

@article{0755c702f4554aaeaa099cc806afd493,
title = "Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice",
abstract = "We reported that invariant NKT-cell knockout (iNKT KO) mice are resistant to the induction of intrathymic chimerism and clonal deletion in the cyclophosphamide (CP)-induced tolerance system (CPS). However, another report shows that clonal deletion with chimerism may be intact in iNKT KO recipients in a bone marrow transplantation model. We also reported that pretreatment with anti-Thy1.2 mAb, which reduces the number of T cells and iNKT cells, promotes allograft tolerance across H-2 barriers in the CPS. In this study, we evaluated the efficacy of T-cell depletion in the CPS, and the relationship between the role played by iNKT cells in central tolerance and mixed chimerism. BALB/c (H-2d) wild-type, or iNKT KO (Jα18-/-) mice were pretreated with 20-100 μg of anti-Thy1.2 mAb and given 108 donor DBA/2 (H-2d) spleen cells on Day 0, and 200 mg/kg CP on Day 2. Pretreatment with T-cell depletion resulted in higher levels of mixed chimerism, increased intrathymic clonal deletion of donor-reactive cells, and the induction of skin graft tolerance in iNKT KO recipients in CPS. This suggests that the high levels of mixed chimerism overcame the resistance to CP-induced tolerance in iNKT KO mice. Consistently, the enhancement of mixed chimerism by injection of tolerant donor spleen cells (SC) rendered iNKT KO recipients susceptible to CP-induced tolerance. These results suggest that iNKT-cell-mediated immunoregulation of central tolerance is evident at low levels of peripheral mixed chimerism in the CPS.",
author = "T. Onzuka and Y. Tomita and S. Okano and I. Shimizu and H. Yamada and Y. Yoshikai and R. Tominaga",
year = "2010",
month = "8",
day = "1",
doi = "10.1111/j.1365-3083.2010.02417.x",
language = "English",
volume = "72",
pages = "106--117",
journal = "Scandinavian Journal of Immunology",
issn = "0300-9475",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice

AU - Onzuka, T.

AU - Tomita, Y.

AU - Okano, S.

AU - Shimizu, I.

AU - Yamada, H.

AU - Yoshikai, Y.

AU - Tominaga, R.

PY - 2010/8/1

Y1 - 2010/8/1

N2 - We reported that invariant NKT-cell knockout (iNKT KO) mice are resistant to the induction of intrathymic chimerism and clonal deletion in the cyclophosphamide (CP)-induced tolerance system (CPS). However, another report shows that clonal deletion with chimerism may be intact in iNKT KO recipients in a bone marrow transplantation model. We also reported that pretreatment with anti-Thy1.2 mAb, which reduces the number of T cells and iNKT cells, promotes allograft tolerance across H-2 barriers in the CPS. In this study, we evaluated the efficacy of T-cell depletion in the CPS, and the relationship between the role played by iNKT cells in central tolerance and mixed chimerism. BALB/c (H-2d) wild-type, or iNKT KO (Jα18-/-) mice were pretreated with 20-100 μg of anti-Thy1.2 mAb and given 108 donor DBA/2 (H-2d) spleen cells on Day 0, and 200 mg/kg CP on Day 2. Pretreatment with T-cell depletion resulted in higher levels of mixed chimerism, increased intrathymic clonal deletion of donor-reactive cells, and the induction of skin graft tolerance in iNKT KO recipients in CPS. This suggests that the high levels of mixed chimerism overcame the resistance to CP-induced tolerance in iNKT KO mice. Consistently, the enhancement of mixed chimerism by injection of tolerant donor spleen cells (SC) rendered iNKT KO recipients susceptible to CP-induced tolerance. These results suggest that iNKT-cell-mediated immunoregulation of central tolerance is evident at low levels of peripheral mixed chimerism in the CPS.

AB - We reported that invariant NKT-cell knockout (iNKT KO) mice are resistant to the induction of intrathymic chimerism and clonal deletion in the cyclophosphamide (CP)-induced tolerance system (CPS). However, another report shows that clonal deletion with chimerism may be intact in iNKT KO recipients in a bone marrow transplantation model. We also reported that pretreatment with anti-Thy1.2 mAb, which reduces the number of T cells and iNKT cells, promotes allograft tolerance across H-2 barriers in the CPS. In this study, we evaluated the efficacy of T-cell depletion in the CPS, and the relationship between the role played by iNKT cells in central tolerance and mixed chimerism. BALB/c (H-2d) wild-type, or iNKT KO (Jα18-/-) mice were pretreated with 20-100 μg of anti-Thy1.2 mAb and given 108 donor DBA/2 (H-2d) spleen cells on Day 0, and 200 mg/kg CP on Day 2. Pretreatment with T-cell depletion resulted in higher levels of mixed chimerism, increased intrathymic clonal deletion of donor-reactive cells, and the induction of skin graft tolerance in iNKT KO recipients in CPS. This suggests that the high levels of mixed chimerism overcame the resistance to CP-induced tolerance in iNKT KO mice. Consistently, the enhancement of mixed chimerism by injection of tolerant donor spleen cells (SC) rendered iNKT KO recipients susceptible to CP-induced tolerance. These results suggest that iNKT-cell-mediated immunoregulation of central tolerance is evident at low levels of peripheral mixed chimerism in the CPS.

UR - http://www.scopus.com/inward/record.url?scp=77954410791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954410791&partnerID=8YFLogxK

U2 - 10.1111/j.1365-3083.2010.02417.x

DO - 10.1111/j.1365-3083.2010.02417.x

M3 - Article

C2 - 20618769

AN - SCOPUS:77954410791

VL - 72

SP - 106

EP - 117

JO - Scandinavian Journal of Immunology

JF - Scandinavian Journal of Immunology

SN - 0300-9475

IS - 2

ER -